Mon, Jul 28, 2014, 10:08 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Skystar Bio Pharmaceutical Company Message Board

  • iq180plus iq180plus Oct 11, 2010 7:20 PM Flag

    SKBI should be concentrating on getting their accounting spic and span.

    When they talk about their accounting controls not being up to snuff, they are keeping the stock at these levels. You must be aware or all the sleezy short smear jobs on these chinese companies. Manangement needs to smarten up.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • gorillagorilla@ymail.com gorillagorilla Oct 12, 2010 5:24 AM Flag

      The main drop occurred when they announced a dilution - which they subsequently recanted on.

      If they can run the business without needing dilution, as they have said they could, then the stock should at least maintain these previous valuations (around $8) - if the vaccine demand is as good as they say then it could start making operating cash and that would be a game changer.

      rich

 
SKBI
5.17-0.15(-2.82%)Jul 28 3:56 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.